A COMPARISON OF ALL-SUBSET COX AND ACCELERATED FAILURE TIME MODELS WITH COX STEP-WISE REGRESSION FOR NODE-POSITIVE BREAST-CANCER

被引:24
作者
CHAPMAN, JAW
TRUDEAU, ME
PRITCHARD, KI
SAWKA, CA
MOBBS, BG
HANNA, WM
KAHN, H
MCCREADY, DR
LICKLEY, LA
机构
[1] UNIV TORONTO,TORONTO BAYVIEW REG CANC CTR,TORONTO M5S 1A1,ONTARIO,CANADA
[2] UNIV TORONTO,SUNNYBROOK HLTH SCI CTR,TORONTO M5S 1A1,ONTARIO,CANADA
关键词
BREAST CANCER; PROGNOSTIC FACTORS; COX REGRESSION; ALL-SUBSET REGRESSION; ACCELERATED FAILURE TIME MODELS;
D O I
10.1007/BF01840839
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Clinical studies usually employ Cox step-wise regression for multivariate investigations of prognostic factors. However, commercial packages now allow the consideration of accelerated failure time models (exponential, Weibull, log logistic, and log normal), if the underlying Cox assumption of proportional hazards is inappropriate. All-subset regressions are feasible for all these models. We studied a group of 378 node positive primary breast cancer patients accrued at the Henrietta Banting Breast Centre of Women's College Hospital, University of Toronto, between January 1, 1977, and December 31, 1986. 85% of these patients had complete prognostic factor data for multivariate analysis, and 96% of the patients were followed to 1990. There was evidence of marked departures from the proportional hazards assumption with two prognostic factors, number of positive nodes and adjuvant systemic therapy. The data strongly supported the log normal model. The all-subset regressions indicated that three models were similarly good. The variables 1) number of positive nodes, 2) tumour size, and 3) adjuvant systemic therapy were included in all three models along with one of three biochemical receptor variables 1) ER, 2) combined receptor (ER- PgR-; ER+ PgR-; ER- PgR+; ER+ PgR+; or 3) PgR. Better multivariate modeling was achieved by using quantitative prognostic factors, a check for appropriate underlying model-type, and all-subset variable selection. All-subset regressions should be considered for routine use with the many new prognostic factors currently under evaluation; it is very possible that there may not be a single model that is substantially better than others with the same number of variables.
引用
收藏
页码:263 / 272
页数:10
相关论文
共 10 条
[1]  
CLARK GM, 1988, SEMIN ONCOL, V15, P20
[2]   RELATION OF ESTROGEN AND OR PROGESTERONE-RECEPTOR CONTENT OF BREAST-CANCER TO PATIENT OUTCOME FOLLOWING ADJUVANT CHEMOTHERAPY [J].
FISHER, B ;
REDMOND, CK ;
WICKERHAM, DL ;
ROCKETTE, HE ;
BROWN, A ;
ALLEGRA, J ;
BOWMAN, D ;
PLOTKIN, D ;
WOLTER, J .
BREAST CANCER RESEARCH AND TREATMENT, 1983, 3 (04) :355-364
[3]  
HARRIS JR, 1987, BREAST DISEASES, P233
[4]  
KALBFLEISCH JD, 1980, STATISTICAL ANAL FAI
[5]   ISMOD - AN ALL-SUBSETS REGRESSION PROGRAM FOR GENERALIZED LINEAR-MODELS .2. PROGRAM GUIDE AND EXAMPLES [J].
LAWLESS, JF ;
SINGHAL, K .
COMPUTER METHODS AND PROGRAMS IN BIOMEDICINE, 1987, 24 (02) :125-134
[6]   ISMOD - AN ALL-SUBSETS REGRESSION PROGRAM FOR GENERALIZED LINEAR-MODELS .1. STATISTICAL AND COMPUTATIONAL BACKGROUND [J].
LAWLESS, JF ;
SINGHAL, K .
COMPUTER METHODS AND PROGRAMS IN BIOMEDICINE, 1987, 24 (02) :117-124
[7]  
LAWLESS JF, 1982, STATISTICAL MODELS M
[8]  
MEAKIN JW, 1978, SEMINARS ONCOLOGY, V5, P445
[9]   CLOSE CORRELATION BETWEEN PROGESTERONE-RECEPTOR CONCENTRATION AND HORMONAL SENSITIVITY IN DMBA-INDUCED MAMMARY-TUMORS OF THE RAT [J].
MOBBS, BG .
EUROPEAN JOURNAL OF CANCER & CLINICAL ONCOLOGY, 1983, 19 (06) :835-842
[10]   PROGNOSTIC VALUE OF ESTROGEN AND PROGESTERONE RECEPTORS IN PRIMARY BREAST-CANCER [J].
SAEZ, S ;
CHEIX, F ;
ASSELAIN, B .
BREAST CANCER RESEARCH AND TREATMENT, 1983, 3 (04) :345-354